Literature DB >> 11859136

Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading.

Xiaodong Feng1, Marcia G Tonnesen, Ellinor I B Peerschke, Berhane Ghebrehiwet.   

Abstract

The interaction of C1q with endothelial cells elicits a multiplicity of biologic responses. Although these responses are presumed to be mediated by the interaction of C1q with endothelial cell surface proteins, the identity of the participants is not known. In this study we examined the roles of two C1q binding proteins, cC1q-R/calreticulin and gC1q-R/p33, in C1q-mediated adhesion and spreading of human dermal microvascular endothelial cells (HDMVEC). When HDMVEC were cultured in microtiter plate wells coated with concentrations of C1q ranging from 0 to 50 microg/ml, a specific and dose-dependent adhesion and spreading was observed. The extent of adhesion and spreading was similar to the adhesion seen on collagen-coated wells. Spreading (68 +/- 12%) and to a moderate extent adhesion (47 +/- 9%) were inhibited by anti-gC1q-R mAb 60.11. Similar effects were noted with polyclonal anti-cC1q-R but not with control nonimmune IgG. The two Abs had a slight additive effect (75 +/- 13% inhibition) when mixed together in the proportion of 100 microg/ml anti-gC1q-R and 30 microg/ml anti-cC1q-R. More importantly, a 100% inhibition of spreading, but not adhesion, to C1q-coated wells was observed when HDMVEC were cultured in the presence of 30 microM of the peptide GRRGDSP but not GRRGESP. Furthermore, while anti-beta(1) integrin Ab blocked both adhesion and spreading, anti-alpha(5) integrin blocked only spreading and not adhesion. Ag capture ELISA of endothelial cell membrane proteins using polyclonal anti-gC1q-R showed the presence of not only beta(1) and alpha(5) integrins but also CD44. Taken together these results suggest that endothelial cell adhesion and spreading require the cooperation of both C1qRs and beta(1) integrins and possibly other membrane-spanning molecules.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11859136     DOI: 10.4049/jimmunol.168.5.2441

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 2.  Exploitation of the ubiquitin system by invading bacteria.

Authors:  Olivia Steele-Mortimer
Journal:  Traffic       Date:  2010-11-24       Impact factor: 6.215

3.  Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium.

Authors:  Roberta Bulla; Chiara Agostinis; Fleur Bossi; Lucia Rizzi; Alessandra Debeus; Claudio Tripodo; Oriano Radillo; Francesco De Seta; Berhane Ghebrehiwet; Francesco Tedesco
Journal:  Mol Immunol       Date:  2008-03-04       Impact factor: 4.407

4.  Anti-C1q antibodies in hepatitis C virus infection.

Authors:  D Saadoun; S Sadallah; M Trendelenburg; N Limal; D Sene; J C Piette; J A Schifferli; P Cacoub
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

5.  Cell-surface receptor for complement component C1q (gC1qR) is a key regulator for lamellipodia formation and cancer metastasis.

Authors:  Ki-Bum Kim; Jae-Sung Yi; Nga Nguyen; Joo-Hyung Lee; Young-Chan Kwon; Byung-Yoon Ahn; Hana Cho; Yoon Ki Kim; Hee-Jung Yoo; Jae-Seon Lee; Young-Gyu Ko
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.157

Review 6.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

7.  DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells.

Authors:  Kinga K Hosszu; Alisa Valentino; Uma Vinayagasundaram; Rama Vinayagasundaram; M Gordon Joyce; Yan Ji; Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  Blood       Date:  2012-06-13       Impact factor: 22.113

8.  A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies.

Authors:  Kristi L Allen; Fabio V Fonseca; Venkaiah Betapudi; Belinda Willard; Jainwei Zhang; Keith R McCrae
Journal:  Blood       Date:  2011-11-21       Impact factor: 22.113

9.  HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway.

Authors:  Hugues Fausther-Bovendo; Vincent Vieillard; Sandrine Sagan; Georges Bismuth; Patrice Debré
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

10.  Evidence that a C1q/C1qR system regulates monocyte-derived dendritic cell differentiation at the interface of innate and acquired immunity.

Authors:  Kinga K Hosszu; Frances Santiago-Schwarz; Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  Innate Immun       Date:  2009-08-26       Impact factor: 2.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.